- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Children (1-11 years)
- Adolescents (12-17 years)
- Outpatient clinic
- Arbovirus
- Dengue virus
- Vector-borne disease
- Blood sample
- Pharmacological intervention
- Vaccination
- Qdenga
Biosamples: Blood sample
- Adults (18-64 years)
- General population
- Infants (<1 year)
- Children (1-11 years)
- Pregnant women
- Community
- Arbovirus
- Vector-borne disease
- Zika virus
- Blood sample
- Urine sample
- Hair
- Saliva
- Semen
- Vaginal fluids
- Adults (18-64 years)
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- PBMC
- Serum
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Intensive care unit
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Community
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- Adults (18-64 years)
- Hospital
- Primary care
- SARS-CoV-2
- Influenza virus
- Blood sample
- PBMC
- Serum
- Whole blood
- Plasma
- Adults (18-64 years)
- Hospital
- Outpatient clinic
- Community
- Primary care
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- Nasopharyngeal swab
- PBMC
- Serum
- Stool sample
- Whole blood
- Plasma
- Adults (18-64 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Blood sample
- Nasopharyngeal swab
- PBMC
- Serum
- Stool sample
- Whole blood
- Adults (18-64 years)
- Hospital
- Primary care
- Emergency department
- Non-hospital health centre
- Long-term care facility
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Blood sample
- Nasopharyngeal swab
- Adults (18-64 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Blood sample
- Nasopharyngeal swab
- Urine sample
- Adults (18-64 years)
- People at high risk of STIs
- PrEP users
- People living with HIV
- Hospital
- Outpatient clinic
- Monkeypox virus
- Blood sample
- Pharmacological intervention
- Vaccination
- MVA-BN